Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Mol Life Sci
2019 Dec 01;7624:4905-4921. doi: 10.1007/s00018-019-03151-z.
Show Gene links
Show Anatomy links
Homology modeling and site-directed mutagenesis identify amino acid residues underlying the substrate selection mechanism of human monocarboxylate transporters 1 (hMCT1) and 4 (hMCT4).
Futagi Y
,
Kobayashi M
,
Narumi K
,
Furugen A
,
Iseki K
.
???displayArticle.abstract???
Human monocarboxylate transporters (hMCTs/SLC16As) mediate the transport of monocarboxylic compounds across plasma membranes. Among the hMCTs, hMCT1 and hMCT4 are expressed in various tissues, and transport substrates involved in energy metabolism. Both transporters mediate L-lactate transport, but, although hMCT1 also transports L-5-oxoproline (L-OPro), this compound is minimally transported by hMCT4. Thus, we were interested in the molecular mechanism responsible for the difference in substrate specificity between hMCT1 and hMCT4. Therefore, we generated 3D structure models of hMCT1 and hMCT4 to identify amino acid residues involved in the substrate specificity of these transporters. We found that the substrate specificity of hMCT1 was regulated by residues involved in turnover number (M69) and substrate affinity (F367), and these residues were responsible for recognizing (directly or indirectly) the -NH- moiety of L-OPro. Furthermore, our homology model of hMCT1 predicted that M69 and F367 participate in hydrophobic interactions with another region of hMCT1, emphasizing its potentially important role in the binding and translocation cycle of L-OPro. Mutagenesis experiments supported this model, showing that efficient L-OPro transport required a hydrophobic, long linear structure at position 69 and a hydrophobic, γ-branched structure at position 367. Our work demonstrated that the amino acid residues, M69 and F367, are key molecular elements for the transport of L-OPro by hMCT1. These two residues may be involved in substrate recognition and/or substrate-induced conformational changes.
Bachhawat,
The glutathione cycle: Glutathione metabolism beyond the γ-glutamyl cycle.
2018, Pubmed
Bachhawat,
The glutathione cycle: Glutathione metabolism beyond the γ-glutamyl cycle.
2018,
Pubmed
Bhattacharya,
3Drefine: an interactive web server for efficient protein structure refinement.
2016,
Pubmed
Carneiro,
Monocarboxylate transporters: new players in body weight regulation.
2015,
Pubmed
Chou,
Fasting serum α‑hydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles.
2018,
Pubmed
Deng,
Molecular basis of ligand recognition and transport by glucose transporters.
2015,
Pubmed
Edwards,
Resculpting the binding pocket of APC superfamily LeuT-fold amino acid transporters.
2018,
Pubmed
Fisel,
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy.
2018,
Pubmed
Futagi,
Identification of a selective inhibitor of human monocarboxylate transporter 4.
2018,
Pubmed
,
Xenbase
Futagi,
The flexible cytoplasmic loop 3 contributes to the substrate affinity of human monocarboxylate transporters.
2017,
Pubmed
,
Xenbase
Galić,
The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
2003,
Pubmed
,
Xenbase
Garcia,
Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle.
1994,
Pubmed
Groeneweg,
The role of Arg445 and Asp498 in the human thyroid hormone transporter MCT8.
2014,
Pubmed
Gui,
Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport.
2008,
Pubmed
Gurrapu,
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
2016,
Pubmed
Heng,
Substrate-bound structure of the E. coli multidrug resistance transporter MdfA.
2015,
Pubmed
Huang,
Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli.
2003,
Pubmed
Iancu,
Crystal structure of a glucose/H+ symporter and its mechanism of action.
2013,
Pubmed
Islam,
Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
2019,
Pubmed
Jefferys,
Protein folding requires crowd control in a simulated cell.
2010,
Pubmed
Jiang,
Structure of the YajR transporter suggests a transport mechanism based on the conserved motif A.
2013,
Pubmed
Johannes,
Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10.
2016,
Pubmed
,
Xenbase
Jones,
Protein secondary structure prediction based on position-specific scoring matrices.
1999,
Pubmed
Kelley,
The Phyre2 web portal for protein modeling, prediction and analysis.
2015,
Pubmed
Kim,
PubChem 2019 update: improved access to chemical data.
2019,
Pubmed
Krypotou,
Modeling, substrate docking, and mutational analysis identify residues essential for the function and specificity of a eukaryotic purine-cytosine NCS1 transporter.
2012,
Pubmed
Lovell,
Structure validation by Calpha geometry: phi,psi and Cbeta deviation.
2003,
Pubmed
Manoharan,
The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity.
2006,
Pubmed
,
Xenbase
Marchler-Bauer,
CD-Search: protein domain annotations on the fly.
2004,
Pubmed
Marchler-Bauer,
CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.
2017,
Pubmed
Menke,
Matt: local flexibility aids protein multiple structure alignment.
2008,
Pubmed
Monné,
Substrate specificity of the two mitochondrial ornithine carriers can be swapped by single mutation in substrate binding site.
2012,
Pubmed
Nancolas,
Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
2015,
Pubmed
,
Xenbase
Ovens,
AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.
2010,
Pubmed
,
Xenbase
Parker,
Molecular basis of nitrate uptake by the plant nitrate transporter NRT1.1.
2014,
Pubmed
Pedersen,
Crystal structure of a eukaryotic phosphate transporter.
2013,
Pubmed
Perland,
Classification Systems of Secondary Active Transporters.
2017,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Pinheiro,
Role of monocarboxylate transporters in human cancers: state of the art.
2012,
Pubmed
Polański,
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
2014,
Pubmed
Qi,
Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis.
2017,
Pubmed
Quanz,
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
2018,
Pubmed
,
Xenbase
Quistgaard,
Understanding transport by the major facilitator superfamily (MFS): structures pave the way.
2016,
Pubmed
Rahman,
Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1.
1999,
Pubmed
,
Xenbase
Remmert,
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment.
2011,
Pubmed
Sasaki,
Effect of diclofenac on SLC16A3/MCT4 by the Caco-2 cell line.
2016,
Pubmed
,
Xenbase
Sasaki,
Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.
2015,
Pubmed
,
Xenbase
Sasaki,
Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4).
2013,
Pubmed
,
Xenbase
Shapovalov,
A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions.
2011,
Pubmed
Sievers,
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
2011,
Pubmed
Stäubli,
Abnormal creatine transport of mutations in monocarboxylate transporter 12 (MCT12) found in patients with age-related cataract can be partially rescued by exogenous chaperone CD147.
2017,
Pubmed
,
Xenbase
Sun,
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4.
2012,
Pubmed
Sun,
Crystal structure of the plant dual-affinity nitrate transporter NRT1.1.
2014,
Pubmed
Söding,
Protein homology detection by HMM-HMM comparison.
2005,
Pubmed
Thiesen,
In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1.
2015,
Pubmed
,
Xenbase
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Vivian,
Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.
2014,
Pubmed
Wang,
Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.
2014,
Pubmed
Wang,
Automatic atom type and bond type perception in molecular mechanical calculations.
2006,
Pubmed
Xie,
Residue-rotamer-reduction algorithm for the protein side-chain conformation problem.
2006,
Pubmed
Yan,
Structure and mechanism of a nitrate transporter.
2013,
Pubmed
Yu,
Serum metabolomic profiling and incident CKD among African Americans.
2014,
Pubmed